Co-Diagnostics IncNASDAQ:CODX
- LAST PRICE1.1700
- TODAY'S CHANGE (%)-0.0100 (-0.8475%)
- Bid / Lots1.1500/ 6
- Ask / Lots1.1800/ 1
- Open / Previous Close1.1800 / 1.1800
- Day Range
- 52 Week Range
- Volume34,522
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CODX |
|---|---|---|
| 09:32 ET | 1882 | 1.18 |
| 09:33 ET | 264 | 1.1775 |
| 09:37 ET | 200 | 1.15 |
| 09:42 ET | 1670 | 1.165 |
| 09:53 ET | 100 | 1.18 |
| 10:02 ET | 100 | 1.18 |
| 10:26 ET | 100 | 1.18 |
| 10:27 ET | 920 | 1.1533 |
| 10:29 ET | 100 | 1.18 |
| 10:33 ET | 2242 | 1.17 |
| 10:40 ET | 700 | 1.17 |
| 10:44 ET | 600 | 1.1653 |
| 10:58 ET | 100 | 1.165 |
| 11:00 ET | 300 | 1.165 |
| 11:03 ET | 100 | 1.1606 |
| 11:09 ET | 550 | 1.165 |
| 11:12 ET | 205 | 1.165 |
| 11:27 ET | 100 | 1.165 |
| 11:34 ET | 1575 | 1.15 |
| 11:41 ET | 200 | 1.16 |
| 11:45 ET | 100 | 1.155 |
| 11:50 ET | 100 | 1.16 |
| 12:28 ET | 100 | 1.17 |
| 12:57 ET | 501 | 1.1609 |
| 01:02 ET | 200 | 1.16 |
| 01:08 ET | 100 | 1.17 |
| 01:24 ET | 200 | 1.16 |
| 01:31 ET | 866 | 1.17 |
| 01:47 ET | 100 | 1.165 |
| 01:49 ET | 200 | 1.165 |
| 02:00 ET | 100 | 1.17 |
| 02:02 ET | 550 | 1.165 |
| 02:12 ET | 100 | 1.165 |
| 02:23 ET | 2023 | 1.17 |
| 02:30 ET | 320 | 1.1626 |
| 02:36 ET | 100 | 1.17 |
| 02:43 ET | 100 | 1.17 |
| 02:56 ET | 900 | 1.1685 |
| 02:59 ET | 300 | 1.1606 |
| 03:06 ET | 3472 | 1.1601 |
| 03:08 ET | 400 | 1.165 |
| 03:10 ET | 100 | 1.17 |
| 03:15 ET | 2023 | 1.17 |
| 03:26 ET | 100 | 1.17 |
| 03:35 ET | 100 | 1.17 |
| 03:48 ET | 100 | 1.17 |
| 03:55 ET | 100 | 1.17 |
| 03:57 ET | 411 | 1.165 |
| 04:00 ET | 3357 | 1.17 |
Yesterday
DJ Co-Diagnostics Price Target Maintained With a $1.50/Share by HC Wainwright & Co., from 6:55AM ET on Monday Nov 11, 2024 by Dow Jones
6:55AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 7, 2024
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
4:01PM ET on Thursday Nov 07, 2024 by Dow Jones*DJ Co-Diagnostics 3Q Loss/Shr 32c >CODX, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in D sseldorf, Germany on Nov 11-14, 2024, from 9:30AM ET on Tuesday Nov 05, 2024 by Dow Jones
9:30AM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 25, 2024
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast, from 4:01PM ET on Friday Oct 25, 2024 by Dow Jones
4:01PM ET on Friday Oct 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Co-Diagnostics Inc | 37.7M | -0.8x | --- |
Icecure Medical Ltd | 30.2M | -2.0x | --- |
T2 Biosystems Inc | 10.4M | 0.0x | --- |
Neuroone Medical Technologies Corp | 27.7M | -1.8x | --- |
Renalytix PLC | 34.5M | -0.2x | --- |
Milestone Scientific Inc | 54.1M | -11.4x | --- |
Company Information
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Contact Information
- Headquarters
- 4049 S Highland DrSALT LAKE CITY, UT, United States 84124-1664
- Phone
- 801-278-9769
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Dwight Egan
- President
- Richard Abbott
- Chief Financial Officer, Company Secretary
- Brian Brown
- Chief Operations Officer
- David Nielsen
- Chief Technology Officer
- Christopher Thurston
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $37.7M |
|---|---|
Revenue (TTM) | $7.3M |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.85 |
EPS | $-1.38 |
Book Value | $2.75 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -549.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
